Develop Type 1 Diabetes Cure
Budget: ₹2,500,000 – ₹5,000,000 INR
I want to push beyond conventional insulin-replacement therapy and map a realistic, science-grounded route to a true cure for Type 1 diabetes. I’m therefore seeking a senior medical researcher, biotechnologist, or pharmaceutical scientist who can synthesize current findings, identify promising regenerative or immune-modulating strategies, and design the next actionable step—whether that becomes a pre-clinical study, a prototype biologic, or the framework for a first-in-human trial.
You will begin with an in-depth literature and patent landscape review, then craft a coherent therapeutic concept that addresses β-cell restoration and long-term immune tolerance. From there, outline the experimental model, key assays, expected endpoints, regulatory considerations, and approximate timelines.
Deliverables
• Comprehensive report (state of the art, research gaps, proposed mechanism of action).
• Step-by-step development plan leading to a viable treatment candidate, including projected milestones and resources.
I’m happy to discuss access to journal databases, lab collaborators, or other resources you might need. Please detail your relevant publications or past project experience when you respond, along with any initial thoughts on which therapeutic avenues—gene editing, stem-cell-derived islets, antigen-specific tolerance, or combination approaches—you believe hold the most promise.
You will begin with an in-depth literature and patent landscape review, then craft a coherent therapeutic concept that addresses β-cell restoration and long-term immune tolerance. From there, outline the experimental model, key assays, expected endpoints, regulatory considerations, and approximate timelines.
Deliverables
• Comprehensive report (state of the art, research gaps, proposed mechanism of action).
• Step-by-step development plan leading to a viable treatment candidate, including projected milestones and resources.
I’m happy to discuss access to journal databases, lab collaborators, or other resources you might need. Please detail your relevant publications or past project experience when you respond, along with any initial thoughts on which therapeutic avenues—gene editing, stem-cell-derived islets, antigen-specific tolerance, or combination approaches—you believe hold the most promise.